Investor Presentation • May 18, 2022
Investor Presentation
Open in ViewerOpens in native device viewer

1

DISCLAIMER This presentation was prepared by Turpaz Industries Ltd. (the "Company") for the sole purpose of conveying information regarding the Company and its subsidiaries (together with the Company "Turpaz Group"). This presentation does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities of the Company and is intended to provide information only. This presentation is not intended to replace the need to review the Company's full reports to the Securities Authority and the Tel Aviv Stock Exchange Ltd. (hereinafter: "Company Reports") prior to making a decision regarding investment in the Company's securities.
In addition, this presentation cannot replace investment consulting by a lawfully licensed investment consultant.
This presentation includes statements data, forecasts, goals and Company plans that are "forward-looking statements", as defined in the Securities Law - 1968, whose occurrence is not certain, and which are not solely in the Company's control. These forward-looking statements are included, inter alia, in discussions of strategy, objectives, goals, plans, events, future intentions or other information relating to future events or issues whose occurrence is not certain.
By their nature, forward-looking statements involve risk and uncertainty. Whether the forward-looking information occurs or not is affected, inter alia, by risk factors characteristic to the Company's operations and developments in the general environment and external factors which impact the Turpaz Group and its area of activities.
Subject to the requirements of applicable law, the Company does not intend to update any industry information or forward-looking statements appearing in this presentation and is not required to publish any additional presentations for its shareholders in future.
Sales \$ 27.4M + 42.5% Sales growth + 9.5% Organic growth Gross profit \$ 10.7 Strong cash flow from operation \$ 5.4M
\$ 6.3M +35.4% Accomplished 6 acquisitions from IPO (May 21) – 3 in 2022 (1 reflected in Q1 and 2
Adjusted EBITDA
Turpaz implemented a strategy of rapid double-digit growth, combining organic growth with synergistic and strategic acquisition

4 (*) Adj EBITDA - earnings before interest, taxes, depreciation, and amortization neutralization of one-time expenses of acquisitions (**) based on the company's internal reporting
| In K US \$ / % | Q1 2021 | Q1 2022 |
|---|---|---|
| Sales | 19,237 | 27,405 |
| Gross profit | 7,490 38.9% |
10,704 39.1% |
| Operating profit | 3,868 20.1% |
4,557 16.6% (*) |
| Adj. EBITDA | 4,667 | 6,318 |
(*) Decrease in operating margin due to:
(1) \$350K - amortization of intangible assets
(2) \$150K - option share-based payment
(3) \$400K - recruitment of management teams and strengthening of the company's managerial infrastructure
| FRAGRANCES | |||
|---|---|---|---|
| In K US \$ / % | Q1 2021 | Q1 2022 | |
| Sales | 4,332 | 5,992 | |
| Operating profit | 1,533 35.5% |
1,793 30.0% |
|
| Organic growth | +13.6% | ||
| Acquisitions | Lori | ||
| Highlights | Strong organic growth LORI profitability is |
lower than segment profitably |
|
| 6 |
| TASTE | ||||
|---|---|---|---|---|
| In K US \$ / % | Q1 2021 | Q1 2022 | ||
| Sales | 6,146 | 13,198 | ||
| Operating profit | 274 4.5% |
1,743 13.2% |
||
| Organic growth | +17.9% | |||
| Acquisitions | 2021- Pilpel & Galilee Herb, FIT 2022(*) - Balirom and Pentaor |
|||
| Highlights | Acquisitions and Profitably product lines & |
organic growth brought strong growth. SDA's increased due to improvement of operational efficiency. |
(*) will contribute to the company's financial results from Q2 2022
| P- INTERMEDIATES P |
|||
|---|---|---|---|
| In K US \$ / % | Q1 2021 | Q1 2022 | |
| Sales | 5,287 | 3,285 | |
| Operating profit | 1,612 30.5% |
923 28.1% |
|
| Organic growth | -35.4% | ||
| Highlights | Revenues decreased mainly due to timing difference of receiving orders from North American customers. Profitability mainly affected from Euro USD impacts. |

| S - INTERMEDIATES S |
||||
|---|---|---|---|---|
| In K US \$ / % | Q1 2021 | Q1 2022 | ||
| Sales | 3,482 | 4,930 | ||
| Operating profit | 1,010 29.0% |
1,275 25.9% |
||
| Organic growth | 44.0% | |||
| Highlights | Revenues increased in receiving orders Profitability mainly |
mainly due to timing different from Asian customers. affected from Euro USD impacts. |



| K US \$ |
2021 | Q1 2021 | Q1 2022 |
|---|---|---|---|
| Revenues | 85,334 | 19,237 | 27,405 |
| Gross Profit | 34,728 | 7,490 | 10,704 |
| GP% | 40.7% | 38.9% | 39.1% |
| R&D Expenses | 1,949 | 387 | 785 |
| Sales & Marketing expenses | 6,274 | 1,200 | 2,343 |
| Management & General expenses | 10,257 | 1,982 | 3,027 |
| Other Expense (Income) | 208 | 53 | )8( |
| Operating Profit | 16,040 | 3,868 | 4,557 |
| OP% | 18.8% | 20.1% | 16.6% |
| Net Profit | 12,812 | 3,122 | 3,960 |
| EBIDTA | 20,021 | 4,667 | 6,213 |
| Adj. EBIDTA (*) | 20,475 | 4,667 | 6,318 |
| % Adj. EBIDTA | 24.0% | 24.3% | 23.1% |
| Cash flow from operation | 12,283 | 1,875 | 5,368 |
* Q1 2022 non-recurring expenses included legal and other expenses relating to acquisitions during the reporting period, amounting to \$105K.
| K US \$ |
31/12/2021 | 31/3/2021 | 31/3/2022 | |||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Current Assets | 106,082 | 36,541 | 99,208 | |||
| Non-Current Assets | 66,587 | 34,350 | 79,143 | |||
| Total Assets | 172,669 | 70,891 | 178,351 | |||
| Liabilities & Equity | ||||||
| Current Liabilities | 37,032 | 28,246 | 38,176 | |||
| Non-Current Liabilities | 42,521 | 27,205 | 49,091 | |||
| Equity | 93,116 | 15,440 | 91,084 | |||
| Total Liabilities and Equity | 172,669 | 70,891 | 178,351 |
| Ratio | |||||
|---|---|---|---|---|---|
| Working capital to sales | 24.2% | 27.4% | 22.6% | ||
| Net Cash (Net Debts)(*) | 20,911 | (18,944) | 6,579 | ||
| Equity to total balance sheet | 54% | 22% | 51% |
(*) Debts = Short and long-term loans from banks and other and liabilities relating to acquisitions






Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.